Thematic Support - Disease Control and Elimination

专题支持——疾病控制和消除

基本信息

  • 批准号:
    MC_UU_00031/1
  • 负责人:
  • 金额:
    $ 317.7万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Intramural
  • 财政年份:
    2022
  • 资助国家:
    英国
  • 起止时间:
    2022 至 无数据
  • 项目状态:
    未结题

项目摘要

The theme has a large portfolio that includes research aimed to decrease the burden of the most common causes of illness and mortality in the West African region, namely malaria, infections caused by bacteria and infections caused by viruses. From the start of the COVID-19 pandemic, the theme has developed a large portfolio to try to understand the effect of the pandemic in the country and why the severity of the infections has been lower than anticipated. The research conducted by the Theme has generated knowledge in the different areas. Some key examples follow:- Research at the theme works on the control of malaria (to decrease the annual number of cases) and elimination (to reach the 0 cases). In malaria control, the Unit has worked along with the National Malaria Control Program to monitor the efficacy of different anti-malarial medicines and with the results update the National treatment policy of malaria patients. In malaria elimination, the theme has designed novel interventions against malaria in regions where the number of cases is very low (reactive treatment). These studies are important in pre-elimination stages. - Research conducted by the theme has informed national and international policies on the immunization with the Pneumococcal conjugate vaccine. This is important as Pneumococcus is still a main contributor of under-5 mortality in the region.- The Theme provided data for the introduction of the Rotavirus vaccine in the country followed by data on the effect of the vaccine in reducing Rotavirus cases and deaths. - During 2020, the first wave of COVID-19 disease did not increase mortality in the rural areas of the country.
该主题有一个很大的组合,其中包括旨在减轻西非区域最常见的疾病和死亡原因的负担的研究,即疟疾、细菌引起的感染和病毒引起的感染。自2019冠状病毒病大流行开始以来,该主题编制了一个庞大的组合,试图了解大流行对该国的影响,以及为什么感染的严重程度低于预期。主题进行的研究产生了不同领域的知识。以下是一些关键的例子:-本主题的研究工作是控制疟疾(减少每年病例数)和消除疟疾(达到零病例)。在疟疾控制方面,该股与国家疟疾控制规划合作,监测不同抗疟疾药物的疗效,并根据监测结果更新国家疟疾患者治疗政策。在消除疟疾方面,该主题在病例数极低的地区设计了新的疟疾干预措施(反应性治疗)。这些研究在消除前阶段很重要。-根据该主题进行的研究为国家和国际关于肺炎球菌结合疫苗免疫的政策提供了信息。这一点很重要,因为肺炎球菌仍然是该区域5岁以下儿童死亡的主要原因。-主题提供了在该国引进轮状病毒疫苗的数据,然后提供了关于疫苗在减少轮状病毒病例和死亡方面效果的数据。- 2020年期间,第一波COVID-19疫情并未增加该国农村地区的死亡率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anna Roca其他文献

Genetic variability among group A and B respiratory syncytial viruses in Mozambique: identification of a new cluster of group B isolates.
莫桑比克 A 组和 B 组呼吸道合胞病毒的遗传变异:鉴定出新的 B 组分离株群。
  • DOI:
    10.1099/0022-1317-82-1-103
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Anna Roca;Mari;L. Quintó;Pilar Pe;rez;N. Vaz;P. Alonso;J. Saiz
  • 通讯作者:
    J. Saiz
Genetic and structural analysis of MBL2 and MASP2 polymorphisms in south-eastern African children.
东南非洲儿童 MBL2 和 MASP2 多态性的遗传和结构分析。
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Xavier Vallès;M. Sarrias;Ferran Casals;Montse Farnós;R. Piñer;B. Suárez;Luis Morais;I. Mandomando;B. Sigaúque;Anna Roca;P. Alonso;Antoni Torres;N. Thielens;Francisco Lozano
  • 通讯作者:
    Francisco Lozano
Differential Features of Colorectal Cancers Fulfilling Amsterdam Criteria without Involvement of the Mutator Pathway Imaging, Diagnosis, Prognosis
不涉及突变途径成像、诊断、预后的情况下满足阿姆斯特丹标准的结直肠癌的差异特征
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    X. Llor;Elisenda Pons;R. Xicola;Antoni Castells;Anna Giro;Anna Roca;M. Gassull
  • 通讯作者:
    M. Gassull
Assessing the impact of Enhanced-Case-Finding on tuberculosis incidence and transmission in The Gambia using epidemiological and phylodynamic approaches
使用流行病学和系统动力学方法评估强化病例发现对冈比亚结核病发病率和传播的影响
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Florian Gehre;Francis Oko;Boatema Ofori;Conor J. Meehan;Etthel M. Windels;Ken Joof;T. Faal;F. Mendy;Tijan Jobarteh;Ensa Gitteh;A. Riley;Binta Sarr;C. Okoi;Edward Demba;William Del;K. Mlaga;Basil Sambou;Fatoumatta Kanuteh;Koduh Lette;Abdul;Shadrac Agbla;W. Mulders;Simon Donkor;David Jeffries;Anna Roca;Umberto D’Alessandro;Martin Antonio;Ifedayo M. O. Adetifa;B. C. Jong
  • 通讯作者:
    B. C. Jong
Inherent illnesses and attacks: an ethnographic study of interpretations of childhood Acute Respiratory Infections (ARIs) in Manhiça, southern Mozambique
  • DOI:
    10.1186/1471-2458-11-556
  • 发表时间:
    2011-07-13
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Lianne Straus;Khátia Munguambe;Quique Bassat;Sonia Machevo;Christopher Pell;Anna Roca;Robert Pool
  • 通讯作者:
    Robert Pool

Anna Roca的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anna Roca', 18)}}的其他基金

Excess mortality during the COVID-19 pandemic in The Gambia: a denominator based analysis within the HDSSs
冈比亚 COVID-19 大流行期间的超额死亡率:HDSS 内基于分母的分析
  • 批准号:
    MC_PC_20028
  • 财政年份:
    2020
  • 资助金额:
    $ 317.7万
  • 项目类别:
    Intramural
Pre-delivery administration of azithromycin to prevent neonatal sepsis and death: a phase III double-blind randomized clinical trial
产前给予阿奇霉素预防新生儿败血症和死亡:一项 III 期双盲随机临床试验
  • 批准号:
    MC_EX_MR/P006949/1
  • 财政年份:
    2016
  • 资助金额:
    $ 317.7万
  • 项目类别:
    Research Grant
Prevention of bacterial infections in the newborn by pre-delivery administration of azithromycin
产前给予阿奇霉素预防新生儿细菌感染
  • 批准号:
    MC_EX_MR/J010391/1
  • 财政年份:
    2012
  • 资助金额:
    $ 317.7万
  • 项目类别:
    Research Grant

相似国自然基金

两性离子载体(zwitterionic support)作为可溶性支载体在液相有机合成中的应用
  • 批准号:
    21002080
  • 批准年份:
    2010
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目
基于Support Vector Machines(SVMs)算法的智能型期权定价模型的研究
  • 批准号:
    70501008
  • 批准年份:
    2005
  • 资助金额:
    17.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Optimising disease surveillance to support decision-making
优化疾病监测以支持决策
  • 批准号:
    DP240102286
  • 财政年份:
    2024
  • 资助金额:
    $ 317.7万
  • 项目类别:
    Discovery Projects
MRC Transition Support Award: Elucidating the role of GCN2 in the pathogenesis of pulmonary vascular disease
MRC 过渡支持奖:阐明 GCN2 在肺血管疾病发病机制中的作用
  • 批准号:
    MR/W029251/1
  • 财政年份:
    2023
  • 资助金额:
    $ 317.7万
  • 项目类别:
    Fellowship
Implementing SafeCare Kenya to Reduce Noncommunicable Disease Burden: Building Community Health Workers' Capacity to Support Parents with Young Children
实施 SafeCare Kenya 以减少非传染性疾病负担:建设社区卫生工作者支持有幼儿的父母的能力
  • 批准号:
    10672785
  • 财政年份:
    2023
  • 资助金额:
    $ 317.7万
  • 项目类别:
Preparing for Blood-Based Alzheimer’s Disease Biomarker Testing in Diverse Populations: Development of a Decision-Support Tool for Primary Care
为不同人群进行基于血液的阿尔茨海默病生物标志物测试做好准备:开发初级保健决策支持工具
  • 批准号:
    10722716
  • 财政年份:
    2023
  • 资助金额:
    $ 317.7万
  • 项目类别:
Guide for Inclusive Support Promoting Preschool Children's Development with Congenital Heart Disease
促进学龄前先天性心脏病儿童发育的包容性支持指南
  • 批准号:
    23K16452
  • 财政年份:
    2023
  • 资助金额:
    $ 317.7万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Biomaterial Manufacturing Suite in Support of NIH/NIAID and the Global Infectious Disease Research Community
支持 NIH/NIAID 和全球传染病研究界的生物材料制造套件
  • 批准号:
    10795293
  • 财政年份:
    2023
  • 资助金额:
    $ 317.7万
  • 项目类别:
Metabolic syndrome impairs oligodendrocyte metabolic support of neurons leading to Alzheimer’s disease/Alzheimer’s disease and related dementias
代谢综合征损害神经元的少突胶质细胞代谢支持,导致阿尔茨海默病/阿尔茨海默病和相关痴呆症
  • 批准号:
    10641057
  • 财政年份:
    2023
  • 资助金额:
    $ 317.7万
  • 项目类别:
CK22-008, Building Mathematical Modeling Workforce Capacity to Support Infectious Disease and Healthcare Research - 2022
CK22-008,建立数学建模劳动力能力以支持传染病和医疗保健研究 - 2022
  • 批准号:
    10913951
  • 财政年份:
    2023
  • 资助金额:
    $ 317.7万
  • 项目类别:
MRC Transition Support Award: The NET-PDD study - defining the roles of NEuroinflammation and Tau aggregation in Parkinson's Disease Dementia
MRC 过渡支持奖:NET-PDD 研究 - 定义神经炎症和 Tau 蛋白聚集在帕金森病痴呆中的作用
  • 批准号:
    MR/W029235/1
  • 财政年份:
    2023
  • 资助金额:
    $ 317.7万
  • 项目类别:
    Fellowship
Infectious Disease Treatment and Decision Support in Terminal Cancer Care
癌症晚期护理中的传染病治疗和决策支持
  • 批准号:
    23K19882
  • 财政年份:
    2023
  • 资助金额:
    $ 317.7万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了